VITAL 1.5KCAL CASE STUDY: MS D

The patient

Ms. D was a 30-year-old married woman with 2 children; pregnant with her third child.

Patient’s situation

Ms. D has a medical history of ulcerative pancolitis, leading to diarrhoea (sometimes with bloody stools), malabsorption, weight loss, a reduced appetite and fatigue. Her pre-pregnancy weight was 46 kg and on referral her weight was 48.5 kg, giving her a BMI of 16.2 kg/m2. Her first 2 children were small for gestational age.

Ms. D was referred to the Maternity Dietetic Services Manager by the local Community Dietitian, who had already advised the patient to follow a low residue diet and take a polymeric oral nutritional supplement (ONS), which Ms. D had been prescribed in previous pregnancies.

On initial assessment, Ms. D’s ONS prescription was changed from a polymeric ONS formula to Vital 1.5kcal, a peptide-based oral nutritional supplement, rich in medium-chain triglycerides. Four weeks later, Ms. D had gained 5.1 kg, reaching 53.6 kg at 22 weeks. Foetal weight gain was excellent. Ms D’s weight continued to increase throughout pregnancy and at final follow up at 38 weeks of gestation, Ms. D weighed 64.5 kg, having experienced a total pregnancy weight gain of 16.9 kg.

Nutritional Intervention

2 x 200 ml bottles Vital 1.5kcal daily – to take as needed as dietary intake was erratic and varied daily.

Nutritional Intervention Goals
  • Optimal nutrition for mum and baby to support maternal and foetal weight gain and foetal growth
  • Meet energy and protein needs during pregnancy
  • Reduce malabsorption and risk of malnutrition
Patient Outcomes

Ms. D experienced good weight gain during her pregnancy of 16.9 kg, which is in line with recommendations. There was some improvement in diarrhoea and taking an ONS also seemed to improve her appetite. Baby also had excellent weight gain and growth.

Ms. D said, ‘Vital 1.5kcal is the only ONS drink I have been able to tolerate. During my pregnancy this time, my appetite was better and I had more energy compared to when I took other ONS drinks in my previous pregnancies’.

Economic impact outcomes

Small for gestational age babies are more likely to experience poor health outcomes in later life, impacting NHS costs. In this case, baby was born at a good weight, being on the 80th centile for weight. He was not small for gestational age, unlike Ms. D’s first two children.

 

RELATED CONTENT

Vital 1.5kcal Case Study: Sue

Sue is a 42 year old female patient with a subtotal colectomy and ileostomy.

Main Image

vital-1500cal-sue

Tagname
CASE STUDY
title
Vital 1.5kcal Case Study: Sue
Content Reference
/content/an/hcpproconnect/uk/en/home/adult/resources/public/vital-1-5-kcal-cs-sue-v2
Abstract

Sue is a 42 year old female patient with a subtotal colectomy and ileostomy. She was admitted to hospital with chronic diarrhoea, and investigation showed evidence of ulceration of the ileosigmoid anastamosis and terminal ileum. During this admission she had numerous medical interventions such as steroid therapy, blood and ferritin transfusions, diuretics and a trial of Creon. She was fed via nasogastric (NG) feeding tube as she was only consuming half of her meals. Previously she had unsuccessfully trialled various whole protein oral nutritional supplements (ONS) and modular supplements, which she had felt exacerbated the diarrhoea.

Publish Date:
July 2020 | 5 min

Vital 1.5kcal Case Study: Rupert

Rupert is a 65 year old male with Ménière’s disease, chronic obstructive pulmonary disease (COPD), depression, angina and previous history of transient ischaemic attacks (TIAs).

Main Image

Tagname
CASE STUDY
title
Vital 1.5kcal Case Study: Rupert
Content Reference
/content/an/hcpproconnect/uk/en/home/adult/resources/public/vital-1-5-kcal-cs-rupert-v2
Abstract

Rupert is a 65 year old male with Ménière’s disease, chronic obstructive pulmonary disease (COPD), depression, angina and previous history of transient ischaemic attacks (TIAs). Rupert was admitted to hospital with gastroenteritis and poorly controlled angina. He develop loose stools (type 7 on the Bristol Stool Chart) which persisted for four weeks and Metronidazole was prescribed for suspected C.difficile. His loose watery stools persisted and after a flexible sigmoidoscopy and colonoscopy were performed, Rupert was diagnosed with non-infective gastroenteritis and colitis. Codeine phosphate, Citalopram, Omeprazole, Prednisolone were trialled during this time. Rupert was only managing to consume a quarter of his meals and was prescribed whole protein oral nutritional supplements (ONS).

Publish Date:
July 2020 | 5 min

Vital 1.5kcal Case Study: Phil

Phil is a 64 year old male undergoing palliative chemotherapy for pancreatic cancer and had a biliary stent in situ.

Main Image

Tagname
CASE STUDY
title
Vital 1.5kcal Case Study: Phil
Content Reference
/content/an/hcpproconnect/uk/en/home/adult/resources/public/vital-1-5kcal-cs-phil-v2
Abstract

Phil is a 64 year old male undergoing palliative chemotherapy for pancreatic cancer and had a biliary stent in situ. He was consuming all of his meals but required additional supplementation to meet his nutritional requirements. Whole protein oral nutritional supplements (ONS) were not tolerated as they exacerbated his diarrhoea.

Publish Date:
July 2020 | 5 min

 

UK-N/A-2300294 | November 2023

Order ID: #12345
Order Date: 01/05/2024
Product Product Flavour Product Quantity
bookmark-icon bookmarked-icon bookmark-hover-icon
Click here to add this page to your bookmarks.

This page has been added to your bookmark. To access your bookmark list, Click this link.

Loading...

Please wait, system loading    

SESSION TIMEOUT

Your session is about to expire in {min} minutes and you will be logged out. Do you wish to stay logged in?
UK-N/A-2400058 (V8) | October 2024

Please log in to continue

Thanks for registering. To begin, please log in to your ProConnect account. After you log in, you’ll have temporary access to all resources and education while we verify your details.

UK-N/A-2400058 (v9) | October 2025

JOIN ABBOTT'S GROWING NETWORK OF HEALTHCARE PROFESSIONALS

Sign up to receive marketing and medical communications from Abbott

Fields marked with an asterisk (*) are mandatory.   

Please enter a valid first name Please enter a first name Please do not add space or special characters on the field
Please enter a valid last name Please enter a last name Please do not add space or special characters on the field
Please enter a valid contact number starting with +44 Please enter a contact number Please enter a valid contact number starting with +44
Please enter a valid email address Please enter an email address Please enter a valid email address
Please enter a valid email address Please confirm your email address Please enter a valid email address
Please enter a valid email address Please enter a valid email address
Please enter a valid email address Please enter a valid email address
 
 
Please select an area of specialty
Only Select a UK place of work. If unable to select/locate one, please fill in manually in Place of Work/Trust. Please enter a valid postcode using the correct format (see information icon above). Please enter a postcode Please enter a valid postcode using the correct format (see information icon above).
Please enter a place of work/trust Please enter a place of work/trust Please enter valid work / trust. Do not use special characters in this box.
Please enter valid address Please enter a street Please enter valid street. Do not use special characters in this box.
Please enter valid city Please enter a city Please enter valid city. Do not use special characters in this box.
Please enter valid county Please enter a county Please enter valid county. Do not use special characters in this box.
Password does not follow password guidelines Please enter a password Password must have at least 8 characters, 1 number, and 1 special character

Password Requirements

Incorrect i18nKey: password-missing-criteria-error
Password must match Please confirm your password

Abbott would like to use your personal data to send to you emails on scientific and educational information, invitations to events, surveys and other relevant communications from Abbott (the “Purpose”). Abbott will not sell or transfer your personal information. Unless you have expressly consented, Abbott will not use it for any other purpose other than the Purpose. To be removed from the Abbott mailing list, you may unsubscribe at any time by managing your preferences in the 'my account' section. Access Abbott's Privacy Policy to learn more about how your data is managed.

 
Please agree to the site's terms of use
 
Please agree to the site's terms of use

Have an account? Login Here

Success or error message

Sorry there has been an error in your registration, please contact our customer service team email: abbott.customerservices@nhs.net
Sorry there has been an error in your registration, please contact our customer service team email: abbott.customerservices@nhs.net
You have registered for an account using abc@gmail.com, however you have not yet activated your account. Please check your inbox for an email from proconnect@abbott.com to activate your account
You might already have an account with ProConnect. abc@gmail.com. Please try and login.
An account associated with abc@gmail.com is already approved and active. Please log in to continue. If you've forgotten your password, reset it here.

UK-N/A-2400058(v9) | September 2025

  • step 1 of 10:Welcome,current
  • step 2 of 10:1,Pending
  • step 3 of 10:2,Pending
  • step 4 of 10:3,Pending
  • step 5 of 10:4,Pending
  • step 6 of 10:5,Pending
  • step 7 of 10:6,Pending
  • step 8 of 10:7,Pending
  • step 9 of 10:8,Pending
  • step 10 of 10:Thank you,Pending
 

Your feedback matters

Please take a quick minute to share your thoughts and help us make your experience even better.

 

Proconnect:

We Value Your Voice - Make Proconnect Work for You

1/8

 
 

Proconnect:

We Value Your Voice - Make Proconnect Work for You

2/8

 
 

Proconnect:

We Value Your Voice - Make Proconnect Work for You

3/8

 
 

Proconnect:

We Value Your Voice - Make Proconnect Work for You

4/8

On a scale of 1 to 5, where 1 is very unsatisfied and 5 is very satisfied, please rate your satisfaction with the following statements.

 
 

Proconnect:

We Value Your Voice - Make Proconnect Work for You

5/8

On a scale of 1 to 5, where 1 is very unsatisfied and 5 is very satisfied, please rate your satisfaction with the following statements.

 
 

Proconnect:

We Value Your Voice - Make Proconnect Work for You

6/8

On a scale of 1 to 5, where 1 is very unsatisfied and 5 is very satisfied, please rate your satisfaction with the following statements.

 
 

Proconnect:

We Value Your Voice - Make Proconnect Work for You

7/8

On a scale of 1 to 5, where 1 is very unsatisfied and 5 is very satisfied, please rate your satisfaction with the following statements.

 
 

Proconnect:

We Value Your Voice - Make Proconnect Work for You

8/8

 

0 = Not likely at all | 4 = Very likely

 

Thank you

 

 Added to Bag

ENSURE PLUS

1 x 220 ml

Flavor: Apple

UK-N/A-2400058 (V9) | October 2025

1,5 kcal / ml

Nutrition Information

Energy
 UnitPer {ml-col-1} mlPer {ml-col-2} ml
 
Vitamins
 UnitPer {ml-col-1} mlPer {ml-col-2} ml
 
Minerals
 UnitPer {ml-col-1} mlPer {ml-col-2} ml
 

footnotes

Product details not available.

 

YOUR ACCOUNT IS PENDING APPROVAL

You have {liteUserDaysLeft} business days of temporary access.
Based on your email address {email} your account has not yet been approved. We’re validating your credentials. You won’t be able to order samples until your account is approved and activated. Please check your email for more details. For help, contact us at abbott.proconnect_access@nhs.net.

UK--2500192 | September 2025

 

ACTIVATION REQUIRED TO GAIN FULL ACCESS

You have {liteUserDaysLeft} business days of temporary access.
Based on your email address {email} your credentials are validated but not yet activated. To gain full access, including the ability to order samples, click the activation link we sent to your inbox. For help, contact us at abbott.proconnect_access@nhs.net.

UK--2500192 | September 2025

WANT TO READ MORE?

Register to continue reading this article

UK-N/A-2400058(v9) | September 2025